Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents

Sponsor
Laval University (Other)
Overall Status
Completed
CT.gov ID
NCT03206606
Collaborator
(none)
104
8
14.6
13
0.9

Study Details

Study Description

Brief Summary

Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic obstructive pulmonary disease (COPD). However, this test remains underused in the primary care. The tools available for its interpretation are little used and the existence of several decision algorithms can create confusion during the diagnosis.

Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical practice (interpretation and prescription of spirometry) of family physicians and family medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval University.

Secondary objective : To evaluate the usability of SPIRO© among family physicians and residents in family medicine working in FMU in Quebec affiliated with Laval University.

Methods: This is a pre-post clinical trial with control group. Participants (family MD and family medicine residents) will be recruited from the various FMU affiliated with Laval University. Participants working in the FMU in the experimental group will be able to use the SPIRO® mobile application to facilitate interpretation of the spirometry test results while participants in the control group will not have access to it during the study. The basic characteristics of the participants and various behavioral parameters based on the theory of planned behavior concerning the interpretation and prescription of spirometry test will be measured. Data from the control group will be collected before those in the experimental group at the time the application is not yet available, which will minimize contamination between groups. The data will be collected with questionnaires delivered in person to the participants before the intervention (T0 time) and then four months later (T1 time) during their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU affiliated with Laval University, who will be randomly assigned to two equal groups: control and experimental. The intervention will consist in sending the SPIRO© mobile application to participants in the experimental group who will use it for a period of four months.

Condition or Disease Intervention/Treatment Phase
  • Device: SPIRO

Detailed Description

Hypothesis : The investigators hypothesize that the use of the SPIRO© application will increase the skills and confidence of family physicians and family medicine residents in prescribing and interpreting spirometry compared to the control group.

The project will be conducted in the following six major steps: 1) Collection of socio-demographic and behavioral characteristics of participants using sections A, B, C and D of the NAPI questionnaire in the control group; 2) Intervention in the control group (they will continue their daily medical practice without being subject to any intervention by our research team), for a period of 4 months; 3) Measurement of behavioral changes in the control group using Sections B, C, D and E of the NAPI questionnaire 4 months after the start of the study; 4) Collection of socio-demographic and behavioral data from participants in the experimental group using sections A, B, C and D of the NAPI questionnaire; 5) E-mail distribution of the application and use of the application by participants in the experimental group for a period of four months, 6) Measurement of behavioral changes in the experimental group after the use of the application, Using sections B, C, D and E of the NAPI questionnaire as well as a questionnaire on the application SPIRO© (SPIRO questionnaire) which will evaluate the usability of this one.

The study has been approved by the research ethic board of the Health and Social Services Center of the old capital - attached to the Integrated Center for Health and Social Services of the National Capital.

Study Design

Study Type:
Observational
Actual Enrollment :
104 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Jul 7, 2017
Actual Study Completion Date :
Dec 20, 2017

Arms and Interventions

Arm Intervention/Treatment
Control Group

Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University.

Experimental Group

Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University that will use the mobile application SPIRO(c) for a period of four months.

Device: SPIRO
Participants in the Experimental Group will be asked to use SPIRO mobile application during a period of 4 months.

Outcome Measures

Primary Outcome Measures

  1. Beliefs about capabilities - interpretation [six weeks]

    The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry.

Secondary Outcome Measures

  1. Beliefs about consequences - prescription [six weeks]

    The beliefs about the consequences of primary care physicians and residents in family medicine regarding prescription of spirometry.

  2. Beliefs about consequences - interpretation [six weeks]

    The beliefs about the consequences of primary care physicians and residents in family medicine regarding interpretation of spirometry.

  3. Beliefs about consequences - use of a mobile application [six weeks]

    The beliefs about the consequences of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.

  4. Moral norms - prescription [six weeks]

    The beliefs about the moral norms of primary care physicians and residents in family medicine regarding prescription of spirometry.

  5. Moral norms - interpretation [six weeks]

    The beliefs about the moral norms of primary care physicians and residents in family medicine regarding interpretation of spirometry.

  6. Moral norms - use of a mobile application [six weeks]

    The beliefs about the moral norms of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.

  7. Intentions - prescription [six weeks]

    The beliefs about the intentions of primary care physicians and residents in family medicine regarding prescription of spirometry.

  8. Intentions - interpretation [six weeks]

    The beliefs about the intentions of primary care physicians and residents in family medicine regarding interpretation of spirometry.

  9. Intentions - use of a mobile application [six weeks]

    The beliefs about the intentions of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.

  10. Social influence - prescription [six weeks]

    The beliefs about the social influence of primary care physicians and residents in family medicine regarding prescription of spirometry.

  11. Social influence - interpretation [six weeks]

    The beliefs about the social influence of primary care physicians and residents in family medicine regarding interpretation of spirometry.

  12. Social influence - use of a mobile application [six weeks]

    The beliefs about the social influence of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.

  13. Belief about capabilities - prescription [six weeks]

    The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding prescription of spirometry.

  14. Belief about capabilities - use of a mobile application [six weeks]

    The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.
Exclusion Criteria:
  • Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UMF de Manicouagan Baie-Comeau Quebec Canada G4Z 3B8
2 UMF de Gaspé Gaspé Quebec Canada G4X 2W2
3 UMF des Etchemins Lac-Etchemin Quebec Canada G0R 1S0
4 UMF de Lévis Lévis Quebec Canada G6W 0J4
5 Unité de médecine familiale - GMF Maizerets Quebec City Quebec Canada G1J 2G1
6 UMF Saint-François d'Assise Quebec City Quebec Canada G1L 3L5
7 Unité de médecine familiale Laval Quebec City Quebec Canada G1V 0B7
8 UMF de Trois-Pistoles Trois-Pistoles Quebec Canada G0L 4K0

Sponsors and Collaborators

  • Laval University

Investigators

  • Principal Investigator: Louis-Philippe Boulet, MD, Heart and Lung Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Louis-Philippe Boulet, Pneumologist, Laval University
ClinicalTrials.gov Identifier:
NCT03206606
Other Study ID Numbers:
  • SPIRO-MD Residents
First Posted:
Jul 2, 2017
Last Update Posted:
Oct 12, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Louis-Philippe Boulet, Pneumologist, Laval University

Study Results

No Results Posted as of Oct 12, 2020